Elizabeth R. Plimack is a Professor of Medical Oncology and the Deputy of Director Fox Chase Cancer. She is an expert on the treatment of genitourinary malignancies with a focus on bladder and kidney cancers.  Her research effort is directed towards the discovery of novel therapeutic approaches and predictive biomarkers for patients with bladder and kidney cancers.

  Dr. Plimack has extensive clinical trial experience with targeted therapy, immunotherapy and novel combination therapies. She serves on the National Comprehensive Cancer Network guidelines panels for Bladder Cancer, chairs the Scientific Advisory Board of the Bladder Cancer Advocacy Network Management and is an elected member of the American Society of Clinical Oncology Board of Directors (2020-2024) who elected her as Treasurer for 2023-2024.  Dr. Plimack has mentored numerous students, residents and fellows and has been among the faculty at the annual AACR/ASCO Methods in Clinical Cancer Research workshop since 2022.

Dr. Plimack received her undergraduate degree from Yale University and completed her M.D. degree and residency in Internal Medicine at the New York University School of Medicine. She went on to a Medical Oncology Fellowship at the MD Anderson Cancer Center, and received a Master’s in Patient Based Biologic Research from the University of Texas Graduate School of Biomedical Science.